• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Community Health Systems Completes Sale of Select Outreach Laboratory Assets to Labcorp

    12/2/25 4:15:00 PM ET
    $CYH
    $LH
    Hospital/Nursing Management
    Health Care
    Medical Specialities
    Health Care
    Get the next $CYH alert in real time by email

    Transaction aims to provide broader access to high-quality testing and laboratory services to communities across the U.S.

    Community Health Systems, Inc. (the "Company") (NYSE:CYH) announced today that its subsidiary, CHS/Community Health Systems, Inc. (CHS), has completed the sale of select assets of the ambulatory outreach laboratory services of CHS-affiliated health systems in 13 states, including certain patient service centers and in-office phlebotomy locations, to Labcorp (NYSE:LH) for approximately $194 million cash, before certain transaction expenses.

    This transaction is expected to provide patients and providers with broader access to Labcorp's comprehensive testing and laboratory services, including its specialty testing menu, robust data analytics and digital tools. The CHS-affiliated health systems will continue to operate their inpatient and emergency department laboratories and provide laboratory services for hospital-based services, such as imaging and pre-admission testing.

    "Completing this transaction with Labcorp allows our health systems to focus on core services and improve the overall patient experience, aligning with our unwavering commitment to providing high-quality, accessible healthcare to our communities," said Kevin Hammons, President and Interim Chief Executive Officer of Community Health Systems, Inc. "Labcorp's scale and investment in technology supports its ability to efficiently deliver outreach laboratory services to patients and healthcare consumers."

    "With the completion of this transaction, Labcorp is expanding access to high-quality, innovative laboratory services for CHS-affiliated health systems' patients and providers and advancing our shared commitment to improving health and lives in the communities we serve," added Mark Schroeder, President of Labcorp Diagnostics and Chief Operations Officer.

    This transaction follows other strategic relationships that Labcorp has developed with a range of health systems and regional/local laboratories that have increased access to laboratory services, improved patient care and driven efficiencies for customers.

    About Community Health Systems, Inc.

    Community Health Systems, Inc. is one of the nation's largest healthcare companies. The Company's affiliates are leading providers of healthcare services, developing and operating healthcare delivery systems in 36 distinct markets across 14 states. The Company's subsidiaries own or lease 69 affiliated hospitals with more than 10,000 beds and operate more than 1,000 sites of care, including physician practices, urgent care centers, freestanding emergency departments, occupational medicine clinics, imaging centers, cancer centers and ambulatory surgery centers. The Company's headquarters are located in Franklin, Tennessee, a suburb south of Nashville. Shares in Community Health Systems, Inc. are traded on the New York Stock Exchange under the symbol "CYH." More information about the Company can be found on its website at www.chs.net.

    About Labcorp

    Labcorp (NYSE:LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp provides insights and advances science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 million tests annually for patients around the world. Learn more about us at www.labcorp.com.

    Cautionary Statement Regarding Forward-Looking Statements

    This press release contains forward-looking statements, including, but not limited to, statements with respect to the anticipated benefits of the transaction between Community Health Systems, Inc. and Labcorp (collectively, "the Companies").

    Each of the forward-looking statements is subject to change based on various important factors, many of which are beyond the control of either of the Companies. These factors, in some cases, have affected and in the future (together with other factors) could affect the Companies' abilities to implement their respective business strategies, and actual results could differ materially from those suggested by these forward-looking statements. As a result, readers are cautioned not to place undue reliance on any of the forward- looking statements.

    Neither of the Companies has an obligation to provide any updates to these forward-looking statements even if their expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. The information in this press release should be read in conjunction with a review of the Companies' respective filings with the SEC. Further information on potential factors, risks and uncertainties that could affect the Companies' respective operating and financial results are included in each of the Companies' most recent annual reports on Form 10-K and subsequent Forms 10-Q and in the Companies' other filings with the SEC.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20251202307359/en/

    Community Health Systems, Inc.

    Media Contact:

    Tomi Galin

    Executive Vice President, Corporate Communications, Marketing and Public Affairs

    (615) 628-6607



    Investor Contacts:

    Kevin Hammons

    President and Interim Chief Executive Officer

    (615) 465-7000



    Anton Hie

    Vice President – Investor Relations

    (615) 465-7012

    Labcorp

    Media Contact:

    Neil Hirsch

    Media@Labcorp.com



    Investor Relations:

    Christin O'Donnell

    Investor@Labcorp.com

    Get the next $CYH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CYH
    $LH

    CompanyDatePrice TargetRatingAnalyst
    Community Health Systems Inc.
    $CYH
    7/24/2025$3.00Buy → Hold
    Jefferies
    Labcorp Holdings Inc.
    $LH
    7/10/2025$260.00Buy → Hold
    HSBC Securities
    Labcorp Holdings Inc.
    $LH
    4/2/2025$276.00Buy
    Redburn Atlantic
    Labcorp Holdings Inc.
    $LH
    3/4/2025$250.00 → $300.00Neutral → Buy
    Citigroup
    Labcorp Holdings Inc.
    $LH
    1/7/2025$260.00 → $265.00In-line → Outperform
    Evercore ISI
    Labcorp Holdings Inc.
    $LH
    12/10/2024$265.00 → $275.00Buy
    Jefferies
    Community Health Systems Inc.
    $CYH
    11/25/2024$5.00 → $2.50Equal Weight → Underweight
    Wells Fargo
    Community Health Systems Inc.
    $CYH
    11/22/2024Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $CYH
    $LH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Smith Wayne T bought $2,110,000 worth of shares (1,000,000 units at $2.11), increasing direct ownership by 24% to 5,107,901 units (SEC Form 4)

    4 - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Issuer)

    11/1/23 4:17:23 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    $CYH
    $LH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Sampson John H

    3 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

    2/11/26 9:04:22 AM ET
    $LH
    Medical Specialities
    Health Care

    Chief Financial Officer, EVP Wang Julia Aijun converted options into 893 shares and covered exercise/tax liability with 254 shares, increasing direct ownership by 113% to 1,202 units (SEC Form 4)

    4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

    2/10/26 3:34:20 PM ET
    $LH
    Medical Specialities
    Health Care

    EVP, Pres of ED, CMO & CSO Caveney Brian J converted options into 1,298 shares and covered exercise/tax liability with 389 shares, increasing direct ownership by 3% to 31,078 units (SEC Form 4)

    4 - LABCORP HOLDINGS INC. (0000920148) (Issuer)

    2/10/26 3:18:03 PM ET
    $LH
    Medical Specialities
    Health Care

    $CYH
    $LH
    SEC Filings

    View All

    SEC Form 144 filed by Labcorp Holdings Inc.

    144 - LABCORP HOLDINGS INC. (0000920148) (Subject)

    2/9/26 1:30:58 PM ET
    $LH
    Medical Specialities
    Health Care

    Labcorp Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LABCORP HOLDINGS INC. (0000920148) (Filer)

    2/9/26 8:34:53 AM ET
    $LH
    Medical Specialities
    Health Care

    Community Health Systems Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Other Events

    8-K - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Filer)

    2/2/26 4:30:26 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    $CYH
    $LH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Community Health downgraded by Jefferies with a new price target

    Jefferies downgraded Community Health from Buy to Hold and set a new price target of $3.00

    7/24/25 7:25:45 AM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Labcorp Holdings Inc. downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Labcorp Holdings Inc. from Buy to Hold and set a new price target of $260.00

    7/10/25 9:03:30 AM ET
    $LH
    Medical Specialities
    Health Care

    Redburn Atlantic initiated coverage on Labcorp Holdings Inc. with a new price target

    Redburn Atlantic initiated coverage of Labcorp Holdings Inc. with a rating of Buy and set a new price target of $276.00

    4/2/25 8:50:29 AM ET
    $LH
    Medical Specialities
    Health Care

    $CYH
    $LH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease Assessment in Primary Care

    Elecsys® pTau-181 test helps clinicians rule out Alzheimer's disease by identifying patients unlikely to have amyloid pathologyNow available nationwide in primary care settings for patients aged 55 and older experiencing symptoms of cognitive declineExpands Labcorp's comprehensive portfolio of Alzheimer's disease blood tests across both primary and specialty care settingsBURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® pTau-181 test, the first and only blood test cleared by the U.S. Food and Drug Administration (FDA) to aid in the initial assessme

    2/11/26 7:00:00 AM ET
    $LH
    Medical Specialities
    Health Care

    Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors

    BURLINGTON, N.C., Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D., Ph.D., MHSc, MBA, to its Board of Directors, effective February 9, 2026. Dr. Sampson serves as vice chancellor for health affairs and dean of the University of Colorado Anschutz School of Medicine at the CU Anschutz medical campus. As a nationally recognized neurosurgeon, physician-scientist and academic leader, Dr. Sampson brings extensive experience spanning clinical care, biomedical r

    2/9/26 8:30:00 AM ET
    $LH
    Medical Specialities
    Health Care

    Community Health Systems to Webcast Fourth Quarter and Year-End 2025 Conference Call

    Community Health Systems, Inc. (NYSE:CYH) today announced that it will webcast its fourth quarter and year-end 2025 conference call. The Company will issue a press release announcing its results on Wednesday February 18, 2026, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Thursday, February 19, 2026. During this call, Community Health Systems will review the Company's financial and operating results for the fourth quarter and full year ended December 31, 2025. A live webcast of the conference call will be available online at https://www.chs.net/investor-relations/investor-tools/webcasts/. An online r

    2/4/26 11:00:00 AM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    $CYH
    $LH
    Financials

    Live finance-specific insights

    View All

    Community Health Systems to Webcast Fourth Quarter and Year-End 2025 Conference Call

    Community Health Systems, Inc. (NYSE:CYH) today announced that it will webcast its fourth quarter and year-end 2025 conference call. The Company will issue a press release announcing its results on Wednesday February 18, 2026, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Eastern Time, on Thursday, February 19, 2026. During this call, Community Health Systems will review the Company's financial and operating results for the fourth quarter and full year ended December 31, 2025. A live webcast of the conference call will be available online at https://www.chs.net/investor-relations/investor-tools/webcasts/. An online r

    2/4/26 11:00:00 AM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026

    BURLINGTON, N.C., Jan. 15, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on Tuesday, February 17, 2026. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website. The call will be webcast live on the Labcorp Investor Relations website. Partici

    1/15/26 4:15:00 PM ET
    $LH
    Medical Specialities
    Health Care

    Labcorp Declares Quarterly Dividend

    BURLINGTON, N.C., Jan. 14, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 12, 2026, to stockholders of record as of the close of business on February 27, 2026. About LabcorpLabcorp (NYSE:LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and c

    1/14/26 6:50:00 AM ET
    $LH
    Medical Specialities
    Health Care

    $CYH
    $LH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Community Health Systems Inc.

    SC 13G/A - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

    11/14/24 5:52:10 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Community Health Systems Inc.

    SC 13G/A - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

    11/14/24 4:11:11 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Community Health Systems Inc.

    SC 13G - COMMUNITY HEALTH SYSTEMS INC (0001108109) (Subject)

    11/13/24 9:31:30 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    $CYH
    $LH
    Leadership Updates

    Live Leadership Updates

    View All

    Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors

    BURLINGTON, N.C., Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D., Ph.D., MHSc, MBA, to its Board of Directors, effective February 9, 2026. Dr. Sampson serves as vice chancellor for health affairs and dean of the University of Colorado Anschutz School of Medicine at the CU Anschutz medical campus. As a nationally recognized neurosurgeon, physician-scientist and academic leader, Dr. Sampson brings extensive experience spanning clinical care, biomedical r

    2/9/26 8:30:00 AM ET
    $LH
    Medical Specialities
    Health Care

    Community Health Systems Appoints Kevin Hammons Chief Executive Officer and Jason Johnson Chief Financial Officer

    Community Health Systems, Inc. (NYSE:CYH) (the "Company" or "CHS") announced today that the Company's Board of Directors has appointed Kevin Hammons to chief executive officer and Jason Johnson to chief financial officer, effective immediately. Hammons and Johnson have been serving in these roles on an interim basis since October 1, 2025. Hammons was also appointed to serve as a member of the Board. "I'm honored to lead the CHS team during a time when we see significant opportunities to advance clinical services, quality and patient care, deeply engage with employees and physicians, and create lasting value for all of our communities and stakeholders," said Kevin Hammons, chief executive o

    12/10/25 4:15:00 PM ET
    $CYH
    Hospital/Nursing Management
    Health Care

    Labcorp Appoints Victor Bulto to Board of Directors

    Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of Victor Bulto, a seasoned pharmaceutical executive and member of Novartis' executive leadership team, to its Board of Directors, effective December 1, 2025. Bulto is an accomplished global executive with 25 years of experience in healthcare, and a proven track record of leadin

    11/24/25 8:30:00 AM ET
    $LH
    Medical Specialities
    Health Care